CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION
Clinical trials for CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION trials appear
Sign up with your email to follow new studies for CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills vs. superbugs: can a stool transplant stop Drug-Resistant infections?
Disease control Not yet recruitingThis study tests whether taking capsules containing healthy donor stool (fecal microbiota transplant) can clear carbapenem-resistant Enterobacteriaceae (CRE) from the gut of hospitalized adults. CRE are hard-to-treat bacteria that can cause serious infections. The trial involves …
Matched conditions: CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated May 17, 2026 05:05 UTC
-
Southern italy launches study to track superbug infections
Knowledge-focused Not yet recruitingThis study will follow 100 adults in southern Italy who have severe infections caused by carbapenem-resistant Enterobacterales (CRE), a type of bacteria that is hard to treat. Researchers want to learn more about the bacteria's resistance patterns and genetic traits to help docto…
Matched conditions: CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTION
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC